Unjha Formul.

{
  "main_header": {
    "sid": 782664,
    "name": "Unjha Formul.",
    "stock_name": "Unjha Formul.",
    "full_name": "Unjha Formulations Ltd",
    "name_url": "stocks-analysis/unjha-formul",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "21.00",
    "chg": 1.49,
    "chgp": "7.64%",
    "dir": 1,
    "prev_price": "19.51",
    "mcapval": "9.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531762,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE576D01015",
    "curr_date": "Apr 16",
    "curr_time": "",
    "bse_nse_vol": "1 ",
    "exc_status": "Active",
    "traded_date": "Apr 16, 2026",
    "traded_date_str": "2026 04 16",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/unjha-formul-782664-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs186-amid-market-pressure-3935953",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/UnjhaFormulatio_priceRelatedfactors_3935953.png",
        "date": "2026-04-07 12:05:09",
        "description": ""
      },
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs1899-amid-market-downturn-3930348",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/UnjhaFormulatio_priceRelatedfactors_3930348.png",
        "date": "2026-04-02 10:43:07",
        "description": ""
      },
      {
        "title": "Why is Unjha Formulations Ltd falling/rising?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/why-is-unjha-formulations-ltd-fallingrising-3908831",
        "imagepath": "",
        "date": "2026-03-24 01:27:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Recent Price Action and Market Context</strong></p>\n<p>Unjha Formulations opened the day with a gap down of 4.53%, signalling immediate bearish sentiment among traders. Throughout the session, the stock traded within a wide range of ₹2.25, with the weighted average price skewed towards the lower end, indicating that more volume was transacted near the day's lows. The stock also experienced high intraday volatility of 5.56%, underscoring the uncertainty and nervousness among investors. Notably, the share price is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a sustained downtrend.</p>\n<p>In comparison, the Pharmaceuticals &amp; Drugs sector, to which Unjha Formulations belongs, declined by 3.58% o..."
      },
      {
        "title": "Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs19-amid-market-downturn-3908352",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/UnjhaFormulatio_priceRelatedfactors_3908352.png",
        "date": "2026-03-23 15:51:49",
        "description": "A sharp decline of 9.31% today dragged Unjha Formulations Ltd to a fresh 52-week low of Rs 19, marking a significant underperformance against both its sector and the broader market. This drop comes amid a broader market sell-off, yet the stock’s fall notably outpaces the sector’s 3.63% decline and the Sensex’s 2.46% fall, highlighting company-specific pressures."
      },
      {
        "title": "Unjha Formulations Ltd Falls to 52-Week Low of Rs.19.15 Amidst Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-falls-to-52-week-low-of-rs1915-amidst-continued-downtrend-3873409",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/UnjhaFormulatio_priceRelatedfactors_3873409.png",
        "date": "2026-03-05 10:10:04",
        "description": "Unjha Formulations Ltd’s shares declined to a fresh 52-week low of Rs.19.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and broader market indices, reflecting persistent concerns over its financial metrics and market positioning."
      },
      {
        "title": "Unjha Formulations Gains 4.32%: Margin Pressures and Flat Growth Shape the Week",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-gains-432-margin-pressures-and-flat-growth-shape-the-week-3826346",
        "imagepath": "",
        "date": "2026-02-07 15:06:27",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>2 Feb:</strong> Stock opens steady at Rs.22.00 amid Sensex decline</p>\n                    <p><strong>3 Feb:</strong> Stock edges up 0.64% as Sensex rallies 2.63%</p>\n                    <p><strong>4 Feb:</strong> Q3 FY26 results reveal profitability plunge and margin pressures</p>\n                    <p><strong>5 Feb:</strong> Flat quarterly performance confirmed; stock surges 2.53%</p>\n                    <p><strong>6 Feb:</strong> Week closes at Rs.22.95, slightly down 0.48% on the day</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.22.00</div></div>\n..."
      },
      {
        "title": "Unjha Formulations Ltd Reports Flat Quarterly Performance Amid Margin Pressures",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/unjha-formulations-ltd-reports-flat-quarterly-performance-amid-margin-pressures-3821507",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnjhaFormulatio_fintrenddot_3821507.png",
        "date": "2026-02-05 08:00:24",
        "description": "Unjha Formulations Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended December 2025, signalling a notable shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, prompting a downgrade in its Mojo Grade to Strong Sell."
      },
      {
        "title": "Are Unjha Formulations Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-unjha-formulations-ltd-latest-results-good-or-bad-3821002",
        "imagepath": "",
        "date": "2026-02-04 19:18:29",
        "description": "Unjha Formulations Ltd's latest financial results for Q3 FY26 reveal a company facing significant operational challenges despite some positive revenue growth. The company reported net sales of ₹4.41 crores, reflecting a year-on-year increase of 17.29% from ₹3.76 crores in Q3 FY25. However, this growth was overshadowed by a sharp decline in profitability, with net profit falling to ₹0.24 crores, a decrease of 70.73% quarter-on-quarter from ₹0.82 crores in Q2 FY26.\n\nThe operating margin also contracted dramatically from 18.41% to 5.67%, indicating severe pressure on cost management and pricing power. This margin compression raises concerns about the company's operational efficiency, especially as employee costs increased significantly during the quarter. The profit after tax margin also deteriorated, dropping to 5.44% from 19.11% in the previous quarter, highlighting vulnerabilities in earnings quality.\n\nDesp..."
      },
      {
        "title": "Unjha Formulations Q3 FY26: Profitability Plunges Amid Margin Compression",
        "link": "https://www.marketsmojo.com/news/result-analysis/unjha-formulations-q3-fy26-profitability-plunges-amid-margin-compression-3820971",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/UnjhaFormulatio_quaterlyResult_3820971.png",
        "date": "2026-02-04 17:46:54",
        "description": "Unjha Formulations Ltd., a Gujarat-based pharmaceutical company specialising in Ayurvedic and Isabgol (Psyllium) formulations, reported a concerning quarter in Q3 FY26, with net profit plummeting 70.73% quarter-on-quarter to ₹0.24 crores from ₹0.82 crores in Q2 FY26. Despite modest revenue growth of 2.80% QoQ, the company's profitability came under severe pressure from margin compression."
      }
    ],
    "total": 137,
    "sid": "782664",
    "stock_news_url": "https://www.marketsmojo.com/news/unjha-formulations-782664"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "10-Apr-2026",
      "details": "Regulation 74(5) of SEBI (DP) Regulation",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "02-Apr-2026",
      "details": "Intimation of Closure of Trading window",
      "source": "BSE"
    },
    {
      "caption": "Disclosures Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011.",
      "datetime": "02-Apr-2026",
      "details": "Regu 31(4) of SEBI ( Sub Acq of share and takeovers) Regulation 2011",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-07 12:05:09

Read full news article

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-04-02 10:43:07

Read full news article

Why is Unjha Formulations Ltd falling/rising?

2026-03-24 01:27:16

Recent Price Action and Market Context

Unjha Formulations opened the day with a gap down of 4.53%, signalling immediate bearish sentiment among traders. Throughout the session, the stock traded within a wide range of ₹2.25, with the weighted average price skewed towards the lower end, indicating that more volume was transacted near the day's lows. The stock also experienced high intraday volatility of 5.56%, underscoring the uncertainty and nervousness among investors. Notably, the share price is currently trading below all major moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, which typically signals a sustained downtrend.

In comparison, the Pharmaceuticals & Drugs sector, to which Unjha Formulations belongs, declined by 3.58% o...

Read full news article

Markets Rally, But Unjha Formulations Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 15:51:49

A sharp decline of 9.31% today dragged Unjha Formulations Ltd to a fresh 52-week low of Rs 19, marking a significant underperformance against both its sector and the broader market. This drop comes amid a broader market sell-off, yet the stock’s fall notably outpaces the sector’s 3.63% decline and the Sensex’s 2.46% fall, highlighting company-specific pressures.

Read full news article

Unjha Formulations Ltd Falls to 52-Week Low of Rs.19.15 Amidst Continued Downtrend

2026-03-05 10:10:04

Unjha Formulations Ltd’s shares declined to a fresh 52-week low of Rs.19.15 today, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has underperformed both its sector and broader market indices, reflecting persistent concerns over its financial metrics and market positioning.

Read full news article

Unjha Formulations Gains 4.32%: Margin Pressures and Flat Growth Shape the Week

2026-02-07 15:06:27

Key Events This Week

2 Feb: Stock opens steady at Rs.22.00 amid Sensex decline

3 Feb: Stock edges up 0.64% as Sensex rallies 2.63%

4 Feb: Q3 FY26 results reveal profitability plunge and margin pressures

5 Feb: Flat quarterly performance confirmed; stock surges 2.53%

6 Feb: Week closes at Rs.22.95, slightly down 0.48% on the day

Week Open

Rs.22.00

...

Read full news article

Unjha Formulations Ltd Reports Flat Quarterly Performance Amid Margin Pressures

2026-02-05 08:00:24

Unjha Formulations Ltd, a player in the Pharmaceuticals & Biotechnology sector, has reported a flat financial performance for the quarter ended December 2025, signalling a notable shift from its previously positive growth trajectory. Despite a modest increase in profit after tax (PAT) over the last six months, the company’s overall financial trend score has deteriorated sharply, prompting a downgrade in its Mojo Grade to Strong Sell.

Read full news article

Are Unjha Formulations Ltd latest results good or bad?

2026-02-04 19:18:29

Unjha Formulations Ltd's latest financial results for Q3 FY26 reveal a company facing significant operational challenges despite some positive revenue growth. The company reported net sales of ₹4.41 crores, reflecting a year-on-year increase of 17.29% from ₹3.76 crores in Q3 FY25. However, this growth was overshadowed by a sharp decline in profitability, with net profit falling to ₹0.24 crores, a decrease of 70.73% quarter-on-quarter from ₹0.82 crores in Q2 FY26. The operating margin also contracted dramatically from 18.41% to 5.67%, indicating severe pressure on cost management and pricing power. This margin compression raises concerns about the company's operational efficiency, especially as employee costs increased significantly during the quarter. The profit after tax margin also deteriorated, dropping to 5.44% from 19.11% in the previous quarter, highlighting vulnerabilities in earnings quality. Desp...

Read full news article

Unjha Formulations Q3 FY26: Profitability Plunges Amid Margin Compression

2026-02-04 17:46:54

Unjha Formulations Ltd., a Gujarat-based pharmaceutical company specialising in Ayurvedic and Isabgol (Psyllium) formulations, reported a concerning quarter in Q3 FY26, with net profit plummeting 70.73% quarter-on-quarter to ₹0.24 crores from ₹0.82 crores in Q2 FY26. Despite modest revenue growth of 2.80% QoQ, the company's profitability came under severe pressure from margin compression.

Read full news article

View All News